Low leptin gene expression and hyperleptinemia in chronic renal failure

Kidney International

Volumn 54, Issue 4, 1998, Pages 1267-1275

  Nordfors, Louise ^b   Lönnqvist, Fredrik ^b   Heimbürger, Olof ^b   Danielsson, Anders ^b   Schalling, Martin ^b   Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

C reactive protein; Chronic renal failure; Glomerular filtration rate; Leptin; Ob gene expression

Indexed keywords

LEPTIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FOOD INTAKE; GENE EXPRESSION REGULATION; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

EID: 0031708589     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00088.x     Document Type: Article

References (37)

1. ZHANG Y, PROENCA R, MAFFEI M, BARONE M, LORI L, FRIEDMAN JM: Positional cloning of the mouse ob gene and its human homolouge. Nature 372:425-432, 1994
2. LEE G-H, PROENCA R, MONTEZ JM, CARROLI KM, DARVISHZADEH JG, LEE JI, FRIEDMAN JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996
3. PELLEYMOUNTER MA, CULLEN MJ, BAKER MB, HECHT R, WINTERS D, BOONE T, COLLINS F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
4. HAALAS JL, GAJIWALA KS, MAFFEI M, COHEN SL, CHAIT BT, RABINOWITZ D, LALLONE RL, BURLEY SK, FRIEDMAN JM: Weight-reduction effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
5. BERGSTRÖM J, LINDHOLM B: Nutrition and adequacy of dialysis: How do hemodialysis and CAPD compare? Kidney Int 43(Suppl 40):S39-S50, 1993
6. MARCKMANN P: Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 29:75-78, 1988
7. BERGSTRÖM J: Why are dialysis patients malnourished? Am J Kidney Dis 26:229-241, 1995
8. HEIMBÜRGER O, LÖNNQVIST F, DANIELSSON A, NORDENSTRÖM J, STENVINKEL P: Serum immunoreactive leptin concentrations and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8:1423-1430, 1997
9. MERABET E, DAGOGO-JACK S, COYNE DW, KLEIN S, SANTIAGO JV, HMIEL SP, LANDT M: Increased plasma leptin concentrations in end-stage renal disease. J Clin Endocrinol Metab 82:847-850, 1997
10. HOWARD J, LORD GM, CLUTTERBUCK EJ, GHATEI MA, PUSEY CD, BLOOM SR: Plasma immunoreactive leptin concentration in end-stage renal disease. Clin Sci 93:119-126, 1997
11. SHARMA K, CONSIDINE RV, BECKIE M, DUNN SR, WEISBERG LS, KURNIK BRC, KURNIK PB, O'CONNOR J, SINHA M, CARO JF: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51:1980-1985, 1997
12. YOUNG GA, WOODROW G, KENDALL S, OLDROYD B, TURNEY JH, BROWNJOHN AM, SMITH MA: Increased plasma leptin/fat ratio in patients with chronic renal failure: A cause of malnutrition? Nephrol Dial Transplant 12:2318-2323, 1997
13. SEELEY RJ, YAGALOFF KA, FISHER SL, BURN P, THIELE TE, VAN DIJK G, BASKIN DG, SCHWARTZ MW: Melanocortin receptor in leptin effects. Nature 390:349, 1997
14. SERRADEIL-LE GAL C, RAUFASTE D, BROSSARD G, POUZET B, MARTY E, MAFFRAND J-P, LE FUR G: Characterization and localisation of leptin receptors in the rat kidney. FEBS Lett 404:185-191, 1997
15. HAMANN A, MATTHAEI S: Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 104:293-300, 1996
16. STENVINKEL P, HEIMBÜRGER O, LÖNNQVIST F: Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12:1321-1325, 1997
17. CUMIN F, BAUM H-P, LEVENS N: Leptin is cleared from the circulation primarily by the kidney. Int J Obesity 20:1120-1126, 1996
18. CUMIN F, BAUM H-P, DE GASPARO M, LEVENS N: Removal of endogenous leptin from the circulation by the kidney. Int J Obesity 21:495-504, 1997
19. SHOJI T, NISHIZAWA Y, EMOTO M, MAEKAWA K, HIURA Y, TANAKA S, KAWAGISHI T, OKUNO Y, MORII H: Renal function and insulin resistance as determinants of plasma leplin levels in patients with NIDDM. Diabetologia 40:676-670, 1997
20. JACOBSSON L: A method for the calculation of the renal clearance based on a single plasma sample. Clin Physiol 3:297-305, 1983
21. ERBA HP, GUNNIG P, KEDES L: Nucleotide sequence of the human gamma cytoskeletal actin mRNA: Anomalous evolution of vertebrate non-muscle actin genes. Nucleic Acids Res 14:5275-5294, 1986
22. LÖNNQVIST F, ARNER P, NORDFORS L, SCHALLING M: Overexpression of the obese (ob) gene in human subjects. Nature Med 1:950-953, 1995
23. LÖNNQVIST F, NORDFORS L, JANSSON M, THÖRNE A, SCHALLING M, ARNER P: Leptin secretion from adipose tissue in women. Relationship to plasma levels and to gene expression. J Clin Invest 99:2398-2404, 1997
24. SCHALLING M, FRIBERG K, SEROOGY K, RIEDERER P, BIRD E, SCHIFFERMANN SN, MAILLEUX P, VANDERHAEGHEN J-J, KUGA S, GOLDSTEIN M, KITHAMA K, LUPPI PH, JOUVET M, HÖKFELT T: Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. Proc Natl Acad Sci USA 87:8427-8431, 1990
25. SINHA MK, OPENTANOVA I, OHANNESIAN J: Evidence of free and bound leptin in the human circulation. J Clin Invest 98:1277-1282, 1996
26. CARO J, KOLAZCYNSKI JW, NYCE MR, OHANNESIAN JP, OPENTATOVA I, GOLDMAN WH, LYNN RB, ZHANG P-L, SINHA MK, CONSIDINE RV: Decreased cerebrospinal fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348:159-161, 1996
27. SCHWARTZ MW, PESKIND E, RASKIND M, BOYKO EJ, PORTE DJ: Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Med 2:589-591, 1996
28. KOLACZYNSKI JW, NYCE MR, CONSIDINE RV, BODEN G, NOLAN JJ, HENRY R, MUDALIAR SR, OLEFSKY J, CARO JF: Acute and chronic effect of insulin on leptin production in humans. Diabetes 45:699-701, 1996
29. BODEN G, CHEN X, KOLACYNSKI JW, POLANSKY M: Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100:1107-1113, 1997
30. DEFRONZO RA, ALVESTRAND A, SMITH D, HENDLER R, HENDLER E, WAHREN J: Insulin resistance in uremia. J Clin Invest 67:563-568, 1981
31. SARRAF P, FREDERICH RC, TURNER EM, MA G, JASKWIAK NT, RIVET D JR, FLIER JS, LOWELL BB, FRAKER DL, ALEXANDER HR: Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 185:171-175, 1997
32. GRUNFELD C, ZHAO C, FULLER J, POLLOCK A, MOSER A, FRIEDMAN JM, FEINGOLD KR: Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 97:2152-2157, 1996
33. KIRCHGESSNER TG, UYSAL T, WIESBROCK SM, MARINO MW, HOTAMISLIGIL GS: Tumour necrosis factor-α contributes to obesity-related hyperleptinaemia by regulating release from adipocytes. J Clin Invest 100:2777-2782, 1997
34. MANTZOROS CS, MOSCHOS S, AVRAMOPOULOS I, KAKLAMANI V, LIOLIOS A, DOULGERAKIS DE, GRIVEAS I, KATSILAMBROS N, FLIER JS: Leptin concentrations in relation to body mass index and the tumour necrosis factor-α system in humans. J Clin Endocrinol Metab 82:3408-3413, 1997
35. PEREIRA BJG, POUTSIAKA DD, KING AJ, STROM JA, NARAYAN G, LEVEY AS, DINARELLO CA: In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 42:1419-1424, 1992
36. HEIMBÜRGER O, LINDHOLM B, BERGSTRÖM J: Nutritional effects and management of chronic peritoneal dialysis, in Nutritional Managment of Renal Disease edited by KOPPLE JD, MASSRY S, Baltimore, William & Wilkins, 1997, pp 619-668
37. HEIMBÜRGER O, DANIELSSON A, KATZARSKI K, STENVINKEL P: Changing body composition with increase in fat mass during one year of CAPD treatment. (abstract) Nephrology 3(Suppl 1):289; 1997